Prostate cancer xenografts and hormone induced prostate carcinogenesis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Differentiation; research in biological diversity

• Publication date

  2017-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.diff.2017.08.005PMID 28923776PMCID PMC6413512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics

  2017cited by this paper
• PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort

  2017cited by this paper
• A community-based model of rapid autopsy in end-stage cancer patients

  2016cited by this paper
• Divergent clonal evolution of castration resistant neuroendocrine prostate cancer

  2016influential reference
• Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

  2015cited by this paper
• Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells.

  2015cited by this paper
• Spatial genomic heterogeneity within localized, multifocal prostate cancer

  2015cited by this paper
• High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.

  2014influential reference
• Neuroendocrine differentiation of prostate cancer: a review.

  2014cited by this paper
• Next generation patient-derived prostate cancer xenograft models

  2014influential reference
• Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.

  2013cited by this paper
• Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.

  2013cited by this paper
• Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia.

  2013cited by this paper
• Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.

  2012cited by this paper
• Role of estrogen in normal male function: clinical implications for patients with prostate cancer on androgen deprivation therapy.

  2011cited by this paper
• Molecular characterization of neuroendocrine prostate cancer (NEPC) and identification of new drug targets.

  2011cited by this paper
• Characterising the castration‐resistant prostate cancer population: a systematic review

  2011cited by this paper
• Estrogen action and prostate cancer

  2011cited by this paper
• CA : A Cancer Journal for Clinicians

  2011cited by this paper
• Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.

  2011cited by this paper
• PC3 is a cell line characteristic of prostatic small cell carcinoma

  2011cited by this paper
• Prostate cancer in dogs: comparative and clinical aspects.

  2009cited by this paper
• Functional Remodeling of Benign Human Prostatic Tissues In Vivo by Spontaneously Immortalized Progenitor and Intermediate Cells

  2009cited by this paper
• A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.

  2009cited by this paper
• Androgen receptor is a tumor suppressor and proliferator in prostate cancer

  2008cited by this paper
• Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling

  2008influential reference
• Mutations in the Androgen Receptor Gene Are Associated with Progression of Human Prostate Cancer to Androgen Independence I

  2008cited by this paper
• Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function.

  2007cited by this paper
• Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1

  2007cited by this paper
• The importance of stroma in morphogenesis and functional activity of urogenital epithelium

  2007cited by this paper
• Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor

  2007cited by this paper
• Steroid hormones stimulate human prostate cancer progression and metastasis

  2006influential reference
• PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor

  2006cited by this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

  2005cited by this paper
• Selection of cell lines with enhanced invasive phenotype from xenografts of the human prostate cancer cell line WPE1-NB26.

  2005cited by this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

  2005cited by this paper
• Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen.

  2005cited by this paper
• Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen.

  2005cited by this paper
• Mutation of the androgen receptor causes oncogenic transformation of the prostate.

  2005cited by this paper
• Development and characterization of efficient xenograft models for benign and malignant human prostate tissue

  2005cited by this paper
• Molecular genetics of human prostate cancer

  2004cited by this paper
• Androgen receptor in prostate cancer.

  2004cited by this paper
• Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence

  2004cited by this paper
• Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

  2004cited by this paper
• Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.

  2003cited by this paper
• LuCaP 35: A new model of prostate cancer progression to androgen independence

  2003cited by this paper
• Role of the stromal microenvironment in carcinogenesis of the prostate

  2003cited by this paper
• Reprints and Subscriptions Permissions

  2003cited by this paper
• A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

  2002cited by this paper
• Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line.

  2002cited by this paper
• Estradiol in elderly men

  2002cited by this paper
• Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.

  2002cited by this paper
• Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate.

  2001cited by this paper
• Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium.

  2001cited by this paper
• A human prostatic epithelial model of hormonal carcinogenesis.

  2001cited by this paper
• Advances in Brief Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer 1

  2001cited by this paper
• Estrogenic effects on prostatic differentiation and carcinogenesis.

  2001cited by this paper
• Malignant transformation in a nontumorigenic human prostatic epithelial cell line.

  2001cited by this paper
• The role of steroid hormones in prostate carcinogenesis.

  2000cited by this paper
• Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.

  2000cited by this paper
• LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis

  2000cited by this paper
• Experimental prostate carcinogenesis - rodent models.

  2000cited by this paper
• Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

  2000cited by this paper
• Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.

  1999cited by this paper
• Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

  1999influential reference
• A new human prostate carcinoma cell line, 22Rv1

  1999cited by this paper
• Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines

  1998cited by this paper
• Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.

  1998cited by this paper
• The mechanism of decomposition of N-methyl-N-nitrosourea (MNU) in water and a study of its reactions with 2'-deoxyguanosine, 2'-deoxyguanosine 5'-monophosphate and d(GTGCAC)

  1997cited by this paper
• Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.

  1997cited by this paper
• Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.

  1996cited by this paper
• The androgen receptor in prostate cancer.

  1996cited by this paper
• Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.

  1996cited by this paper
• Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.

  1996influential reference
• CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

  1996cited by this paper
• Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

  1996cited by this paper
• In vivo amplification of the androgen receptor gene and progression of human prostate cancer

  1995cited by this paper
• Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor.

  1995cited by this paper
• Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

  1994cited by this paper
• Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells

  1994cited by this paper
• Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras.

  1994cited by this paper
• Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

  1994cited by this paper
• CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.

  1994cited by this paper
• Xenografts of primary human prostatic carcinoma.

  1993cited by this paper
• Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate.

  1992cited by this paper
• Metastatic model for human prostate cancer using orthotopic implantation in nude mice.

  1992cited by this paper
• The importance of steroid hormones in prostate cancer.

  1992cited by this paper
• Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice.

  1991cited by this paper
• Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo.

  1990cited by this paper
• A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.

  1990cited by this paper
• Metastatic behavior of human tumor cell lines grown in the nude mouse.

  1984cited by this paper
• LNCaP model of human prostatic carcinoma.

  1983cited by this paper
• The LNCaP cell line--a new model for studies on human prostatic carcinoma.

  1980cited by this paper
• Human prostatic adenocarcinoma: Some characteristics of a serially transplantable line in nude mice (PC 82)

  1980cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper
• The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration.

  1977cited by this paper
• Sex steroids as a cause of adenocarcinoma of the dorsal prostate in Nb rats, and their influence on the growth of transplants.

  1977cited by this paper
• Tissue pressures and fluid dynamics in the kidney.

  1976cited by this paper
• Tissue pressures and fluid dynamics in the kidney.

  1976cited by this paper
• Squamous metaplasia of prostate following estrogen therapy.

  1952cited by this paper

• Patient-derived tumor xenograft study with CDK4/6 inhibitor plus AKT inhibitor for the management of metastatic castration-resistant prostate cancer.

  2024cites this paper
• Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation

  2023influential citation
• Investigation of the regulatory effects of synthesized antisense oligonucleotides on androgen receptor (AR) exon 3 splicing in prostate cancer cells.

  2023cites this paper
• Toxicoproteomics of Mono(2-ethylhexyl) phthalate and Perfluorooctanesulfonic Acid in Models of Prostatic Diseases.

  2023cites this paper
• Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).

  2022cites this paper
• Occurrence of Steroidal Hormone in Environment

  2021cites this paper
• Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research

  2020cites this paper
• Establishment and characterization of patient-derived xenografts for hormone-naïve and castrate-resistant prostate cancers to improve treatment modality evaluation

  2020cites this paper
• Recapitulation of prostate tissue cell type-specific transcriptomes by an in vivo primary prostate tissue xenograft model

  2020cites this paper
• Antitumor and hepatoprotective activity of natural and synthetic neo steroids.

  2020cites this paper
• Experimental Animal Models for Prostate Cancer - A Mini Review

  2020cites this paper
• Cancer Explant Models.

  2019cites this paper
• Development of patient-derived xenograft models of prostate cancer for maintaining tumor heterogeneity.

  2019cites this paper
• Expression and Localization of DDX3 in Prostate Cancer Progression and Metastasis.

  2019cites this paper
• Chemical and Genetic Tools for Probing the Cooperativity of Molecular Chaperones

  2018cites this paper
• Use of immune-deficient hosts to study human development and pathogenesis.

  2017cites this paper